For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical fortunes, Brookfield Asset Management’s plan to take its troubled eponymous company private had been a way to turn it around — far from the glare of markets.

Brookfield Asset Management Ltd. is preparing to walk away from a plan to acquire Grifols SA over disagreements on valuation. The Spanish company’s billionaire founding family said it won’t support any new bid to take its namesake drug-maker private.

Canadian investment fund Brookfield said Wednesday it has dropped its bid for Spanish pharmaceutical firm Grifols following disagreement over its valuation.

Grifols (GRFS) stock dropped as Brookfield Asset Management (BAM) is reportedly withdrawing its offer to take the plasma therapeutics company private. Read more here.